The changing environment for U.S. pharmaceuticals : the role of pharmaceutical companies in a systems approach to health care : a report / prepared by the Boston Consulting Group, Inc. ; sponsored by Pfizer Inc.
Publisher:
The Group,
Copyright Date:
1993
Description:
69 pages, 1 unnumbered page : illustrations ; 28 cm
"April 1993." Includes bibliographical references (pages 67-70).
Contents:
The Reforming the system. The new environment : a price-focused market -- The new environment : R&D challenges and opportunities -- The effect of the new era -- The risks of focusing on pharmaceuticals as one component of the system ; Changes that have created the new era. A market increasingly focused on cost and value. The rise of generic competition -- Managed care as a major market force -- The role of government as a buyer -- Trends in distribution of pharmaceuticals -- Price-sensitive consumers and physicians -- The need to provide economic as well as clinical value -- The impact on pharmaceutical marketing -- Fundamental changes in the pharmaceutical research and development environment. The new scientific challenges and opportunities -- The pharmaceutical industry and biotechnology -- Changes in disease focus -- Changes in the industry's spending on R&D and marketing -- Efforts to enhance effectiveness -- Results of changes in the industry environment. A riskier environment -- The impact of risk and opportunities -- System management with a disease orientation. Reforming the system. The Marketing to improve quality of care. System management with a disease orientation -- The future role of the pharmaceutical industry. Controlling system cost -- Continuing to create medical breakthroughs -- Marketing to improve quality of care.
OCLC:
(OCoLC)28132018
LCCN:
93202609
Locations:
OVUX522 -- University of Iowa Libraries (Iowa City)
This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.